Sympathetic regulation of cardiac contractility is mediated in part by a 1 -adrenergic receptors (ARs), and the a 1A -subtype has been implicated in the pathogenesis of cardiac hypertrophy. However, little is known about a 1A -AR signalling pathways in ventricular myocardium. The aim of this study was to determine the signalling pathway that mediates a 1A -AR-coupled cardiac contractility. 
Introduction
Adrenergic receptor (AR) activation in response to sympathetic nervous system stimulation has a major role in regulating cardiac function.
1,2 Cardiomyocytes (CMs) express both a-and b 1/2 -ARs. In normal adult hearts, cardiac inotropy and chronotropy are predominantly regulated by b 1 -ARs. 1 Under pathological conditions, however, e.g. myocardial ischaemia or hypertrophy, a 1 -ARs function in a compensatory fashion to maintain cardiac inotropy when b 1 -ARs are down-regulated 1, 3 and uncoupled from G proteins and effectors. 4 In addition, although implicated in the pathogenesis of hypertrophy, 5 a 1 -ARs, particularly the a 1A -subtype, are important in both developmental CM growth and survival. 5, 6 Cardiac a 1 -AR stimulation enhances contractility and causes small but significant increases in [Ca 2+ ] i , but underlying mechanisms remain incompletely understood. It has been suggested that a 1 -AR -activation is associated with coupling to the G q/11 family of heterotrimeric G proteins and phospholipase Cb (PLCb) isoform-activation, 7 resulting in phosphatidylinositol(4,5)-bisphosphate hydrolysis to inositol (1, 4, 5) -trisphosphate (IP 3 ) and diacylglycerol (DAG). This results in Ca 2+ mobilization from intracellular stores and Ca 2+ membrane influx. 8 Elevated [Ca 2+ ] i might also be due to (i) store-operated channels (SOCs) activated, for example, by IP 3 -induced Ca 2+ depletion of internal stores or (ii) via receptor-operated channels (ROCs). 9 It is unclear whether these pathways are major contributors to CM a 1 -AR signalling, since PLCb activity and IP 3 generation as well as IP 3 -receptor (IP 3 R) expression are generally low in CMs. 10 Transient receptor potential (TRP) proteins form non-selective cationic channels that are implicated in diverse biological functions, 11 and changes in the expression of canonical TRP channels (TRPCs) have been linked to cardiac hypertrophy development. 11, 12 Some studies suggest that TRPCs act as SOCs; others have shown that they can also function as ROCs. 13 In PC12 cells, interactions between TRPC6 and the adaptor protein, Snapin, regulate a 1A -AR-mediated Ca 2+ influx 14 -Snapin being a SNARE-associated modulatory protein involved in exocytosis and cytokinesis. 15, 16 Here, we utilized a transgenic mouse model with cardiac-restricted a 1A -AR overexpression to show that TRPC6-Snapin interactions determine a 1A -AR signalling, both in isolated CMs and in vivo. In this transgenic model, mice with four-fold a 1A -AR overexpression (a 1A -L) are phenotypically normal, while mice with 66-fold (a 1A -M) and 170-fold (a 1A -H) overexpression display expression-related increases in systolic contractile function. 17 Interestingly, despite increased a 1A -AR expression, none of these mice showed cardiac hypertrophy under baseline conditions, and hypertrophic responses to pressure overload were similar to those in wild-type (WT) littermates. 18 Moreover, while enhanced a 1A -AR-drive in the a 1A -M line improved survival in response to myocardial infarction or pressure overload, 18 
Development of pore inhibitory anti-TRPC1 and TRPC6 antibodies
Rabbit anti-TRPC1 and anti-TRPC6 antibodies, raised (Peptide Specialty Laboratories GmbH, Heidelberg, Germany) against the putative poreforming loop of these TRPCs, were immunoaffinity-purified using the respective peptide immunogens coupled to Cn-Br-activated agarose (see Supplementary material online, Methods for details).
Production of shRNA-encoding adenoviruses
Oligonucleotide sequences for shRNA1-Snapin, shRNA2-Snapin, or shRNA scrambled (see Supplementary material online, Methods) were cloned into the multiple cloning site of pAdTrack-si, 21 and recombinant adenoviruses were generated as described. 22 
Reverse transcriptase -polymerase chain reaction
Snapin, TRPC1, TRPC6, and porphobilinogen deaminase cDNAs were generated from mouse total RNA as detailed in Supplementary material online, Methods.
Immunoblot analysis
Western blotting was performed using antibodies to Snapin, TRPC1, or TRPC6 (see Supplementary material online, Methods).
Cell lines, culture, and transfection
HEK293 and COS cells were cultured in high-glucose Dulbecco's modified Eagle's medium (see Supplementary material online, Methods) and transfected using Lipofectamine 2000 (Invitrogen).
2.7 Isolation, cell culture, and adenoviral infection of ventricular adult mouse CMs a 1A -H and a 1A -M and WT mice were anesthetized with Nembutal (60 mg/kg, ip; anaesthesia depth was monitored by limb withdrawal using toe pinching), a thoracotomy was performed and left ventricular CMs isolated from the hearts by enzymatic retrograde perfusion, 23 as detailed in Supplementary material online, Methods, were incubated for 1 h at 378C and 2% CO 2 in plating media (MEM media containing 10% FCS, 10 mM BDM, 2 mM Penicillin/Streptomycin, 2 mM Glutamine). CMs were then washed two times with culturing media (MEM media containing 0.5% FCS, 2 mM penicillin/streptomycin, 2 mM glutamine) and cultured in culturing media at 378C and 2% CO 2 , with or without adenovirus at MOI 100, for 96 h. 24 
Immunocytochemistry
CMs cultured on laminin-coated glass coverslips were stimulated with methoxamine (100 mmol/L), A61603 (100 nmol/L) and/or prazosin (100 nmol/L), fixed, permeabilized and stained for Snapin, TRPC1, or TRPC6, as detailed in Supplementary material online, Methods.
Transmission electron microscopy and immunogold labelling
Cardiac tissue sections were stained with TRPC1 or TRPC6 with 10 nm colloidal-gold-conjugated antibody, and for Snapin or caveolin antibodies with 20 nm colloidal-gold-conjugated antibody, as detailed in Supplementary material online, Methods. Pictures were taken at ×50 000 magnification.
Measurement of [Ca 21 ] i
Ca 2+ recordings were performed either using batches of isolated, fura-2 AM-loaded CMs in a cuvette to quantify mean fluorescence, or using single-isolated fluo-4 AM-loaded CMs monitored by confocal Ca 2+ microscopy (for details, see Supplementary material online, Methods).
Isolated heart perfusions
Animals were anaesthetized (Nembutal, 60 mg/kg, ip) and a thoracotomy was performed, and hearts from a 1A -H or WT mice were isolated for Langendorff perfusion (detailed in Supplementary material online, Methods). Seven to eight animals were analysed per group.
a 1A -Adrenergic receptor regulation of cardiac contractility
Co-immunoprecipitation
Animals were anesthetized (1.5% isofluorane in medical grade O 2 delivered by nose cone; anaesthesia depth was monitored by limb withdrawal using toe pinching) and a 1.4 Fr Millar catheter introduced in the left carotid artery to monitor arterial blood pressure. After measurement of baseline parameters, saline or PE (WT 100 mg/kg; a 1A -AR-H 3.3 mg/ kg in 25 mL) was delivered over 1 min into the left jugular vein with a 100 mL Hamilton syringe using an sp200i syringe pump. Prazosin (0.5 mg/kg, in 25 mL, ip, 1 min incubation) was administered as a bolus in a volume of 1 mL/kg as indicated. Hearts were quickly extracted at the times indicated, membrane fractions were prepared, solubilized, precleared, incubated with Snapin-FL-antibody covalently coupled to Gsepharose, and proteins eluted for SDS -PAGE electrophoresis as described in Supplementary material online, Methods.
Data analysis
Results shown are means + 1SD. Statistical differences were determined by two-way analysis of variance (two-way ANOVA) for quantification of intensity staining and Ca 2+ recordings and one-way ANOVA for isolated hearts followed by a pairwise comparison, with P ≤ 0.05 being considered significant.
Results

Endogenous expression and subcellular localization of TRPC6, TRPC1, and Snapin in CMs and heart tissue
Immunoblot ( Figure 1A , left panel) and densitometric analyses (data not shown) revealed Snapin, TRPC6, and TRPC1 expression in isolated CMs and in myocardium of a 1A -H and WT mice. Snapin and TRPC6 expression levels were more marked in the myocardium, suggesting that their expression is not limited to CMs, but also occurs in non-CMs. In contrast, expression of TRPC1, a wellcharacterized SOC, was similar in myocardium and in CMs, indicating predominant CM expression. Transmission electron microscopy (TEM) of immunogold-labelled a 1A -H and WT myocardium showed co-localization of Snapin, TRPC6, and TRPC1 in the plasma membrane and the t-tubules; the latter evident from caveolin-3 immunolabelling ( Figure 1B ). Specificity of antibody staining was confirmed by blockade of immunoblotting ( Figure 1A , right panel) with the peptide immunogens used to generate anti-TRPC6 and anti-TRPC1 antibodies.
Dynamic interaction of a 1A -AR, Snapin, and TRPC6 in vitro and in vivo
Prior to CM stimulation with a commonly used a 1 -AR agonist, methoxamine, TRPC6, and Snapin were evident in both the plasma membrane and t-tubules as well as in the cytosol of WT CMs ( Figure 2A -C), with slightly higher plasma membrane vs. intracellular localization in unstimulated a 1A -H CMs ( Figure 2B and C ). a 1 -AR activation resulted in translocation of Snapin and TRPC6 from the t-tubules to the plasma membrane in both WT and a 1A -H CMs, as evident by the loss of tubular staining and a weaker striation pattern ( Figure 2A ). This translocation was abrogated by pre-treatment with the a 1 -AR-specific antagonist, prazosin. In WT CMs, recruitment to the plasma membrane peaked at 5-10 min after a 1 -AR activation ( Figure 2B ), whereas in a 1A -H CMs, plasma membrane recruitment was faster (peaking at 2 min) ( Figure 2C ). In contrast to TRPC6, no significant plasma membrane translocation of TRPC1 was observed with a 1 -AR activation of WT or a 1A -H CMs (see Supplementary material online, Figure S1 ). Next, we investigated whether the interaction of a 1A -AR, Snapin, and TRPC6 observed in vitro was also operative in vivo. Hearts were rapidly excised from a 1A -H and WT mice after administration of phenylephrine (PE) to activate a 1 -ARs or saline. Immunoprecipitation of solubilized membranes with an anti-Snapin antibody showed that a 1A -AR and TRPC6 (but not TRPC1; data not shown) co-immunoprecipitated with Snapin in both a 1A -H mice and WT hearts, even basally after saline administration, although this interaction was greater in a 1A -H mice (see Supplementary material online, Figure S2 ). In the WT, co-immunoprecipitation was maximal at 1.5 min and waned by 7 min after PE administration (see Supplementary material online, Figure S2 ). In both genotypes, this interaction was increased after a 1 -AR activation, although to a greater extent in a 1A -H mice (see Supplementary material online, Figure  S2B ). These data indicate a dynamic interaction between a 1A -AR, Snapin, and TRPC6 in vivo.
Increased [Ca
21
] i in a 1A -M and a 1A -H relative to WT CMs after a 1 A-AR activation
To provide more robust evidence for an interaction between a 1A -AR, Snapin, and TRPC6, we used the highly selective a 1A -AR agonist, A61603, in subsequent studies. Consistent with very low a 1A -AR expression in WT CMs, 1 receptor stimulation with A61603 resulted in only a slight increase in [Ca 2+ ] i in these cells, which was only significant at the highest A61603 dose (30 nM; Figure 3A ). Figure 3C , addition of non-specific TRPC channel-and ROC/SOC inhibitors, La 3+ or gentamicin, to batches of CMs from a 1A -H or WT mice suppressed a 1A -AR-mediated increases in [Ca 2+ ] i , whereas inhibition of store-operated Ca 2+ entry (SOCE) with 2-APB, or IP 3 -mediated signalling with xestospongin C, had no effect. To demonstrate ROCE, CMs were treated with ROC/SOC inhibitors, La 3+ , and gentamicin, as well as the SOCE inhibitor, 2-APB, after initial depletion of the sarcoplasmic reticulum (SR) Ca 2+ -ATPase using cyclopiazonic acid (CPA) and/or after caffeine-induced release from the ryanodine-sensitive Ca 2+ pool. As shown in Figure 3D -G, increases in [Ca 2+ ] i resulting from enhanced Ca 2+ influx due to a 1A -AR stimulation with A61603 were observed after CPA pre-treatment, which depletes intracellular stores and pre-activates SOCs. 27, 28 Of interest, similar responses were observed in studies of single-isolated CMs where cells were pre-treated with both CPA and caffeine (see Supplementary material online, Figure S3A ). Moreover, in both studies of CM batches ( Figure 3D and E) and single-isolated CMs (see Supplementary material online, Figure S3A ), a 1A -AR-stimulated Ca 2+ influx was observed only if Ca 2+ was present in the extracellular medium. Influx was not evident in the absence of extracellular Ca 2+ but could be restored by the addition of external Ca 2+ to a 1A -H CMs (Figure 3F and G;
see Supplementary material online, Figure S3B ). Figure S3A and B). online, Figure S3C ). In this situation, no increase in cytoplasmic Ca 2+ was observed (see Supplementary material online, Figure S3C ), arguing against a mechanism involving activation of SOCE, which would be expected to result in an influx of Ca 2+ , independent of a 1A -AR activity. This scenario largely excludes SOCE, which is Solubilized membranes (120 mg) from WT or a 1A -H CMs or heart tissue were fractionated on 6% SDS -PAGE for TRPC6 ( 107 kDa) and TRPC1 ( 93 kDa) or 15% SDS -PAGE for Snapin ( 15 kDa) followed by immunoblotting with anti-Snapin, or anti-TRPC6, or anti-TRPC1 antibody in the absence (2) (left panels) or presence (+) (right panels) of their specific peptide immunogen. As loading controls, solubilized membranes were similarly evaluated with anti-GAPDH antibody. (B) Double immunogold labelling with anti-TRPC6 (small-10 nm gold particles, arrowhead) and antiSnapin (large-20 nm gold particles, arrow) antibodies. I and II show co-localization of TRPC6 and Snapin along the plasma membrane (I), and at the ends of sarcomere Z-lines localized to t-tubules. T-tubule localization of TRPC6 was confirmed by double immunogold labelling of anti-TRPC6 (10 nm particles) and t-tubule-specific anti-caveolin-3 antibodies (20 nm particles) (III and IV). Both proteins co-localize at the t-tubules (arrows). TRPC1 showed a similar pattern of expression to TRPC6 (not shown). BV, blood vessel; Nu, nucleus. Scale bars: I, II, and IV ¼ 200 nm; III ¼ 500 nm. Images were obtained using a JEOL1400 TEM microscope at ×50 000.
a 1A -Adrenergic receptor regulation of cardiac contractility known to be restricted to an a 1A -AR-activation-independent Stim1 -Orai1 interaction. 29 To verify that a 1A -AR-mediated Ca 2+ influx is dependent on TRPC6 activity, cells were pre-incubated with anti-TRPC6 antibody and then a 1A -ARs were activated after store depletion in Ca 2+ -free medium (see Supplementary material online, Figure S3D ). This resulted in a continued decline in fluo-4 signal, most likely due to further Ca 2+ efflux as a result of continued activity of sodium-calcium exchangers and plasma membrane Ca 2+ -ATPases. Figure 4A ) and in single-isolated CMs using one effective antibody concentration (see Supplementary material online, Figure S3D ). In contrast to the very pronounced effect of the anti-TRPC6 antibody, the anti-TRPC1 antibody had a much smaller effect on A61603-mediated increases in cytoplasmic Ca 2+ in a 1A -H CMs ( Figure 4A ). Moreover, neither TRPC1 nor TRPC6 pre-immune serum affected a 1A -AR-mediated increases in [Ca 2+ ] i (see Supplementary material online, Figure S4 ). Snapin knockdown also attenuated a 1A -AR-mediated Ca 2+ entry. This is shown in Figure 4B , where Snapin knockdown was achieved by infection of CMs with either of two adenoviruses encoding anti-Snapin shRNA. In contrast, a 1A -AR-mediated Ca 2+ entry was evident in uninfected CMs or in cells infected with an adenovirus encoding a scrambled anti-Snapin shRNA. Functionality and specificity of anti-Snapin-specific shRNA-adenoviruses was demonstrated by reverse transcriptasepolymerase chain reaction and immunoblotting (see Supplementary material online, Figure S5 ), where the steady-state level of Snapin mRNA was markedly suppressed 96 h after adenoviral infection with either Snapin-specific shRNA adenovirus, as was Snapin protein expression. In contrast, in CMs infected with adenovirus encoding scrambled anti-Snapin shRNA, Snapin transcript, and protein expression were unaltered. Snapin residues targeted by the two anti-Snapin shRNAs (shRNA1-Snapin and shRNA2-Snapin) are indicated in Supplementary material online, Figure S5E . Taken together, these findings indicate that both Snapin and TRPC6 are required for a 1A -AR-stimulated Ca 2+ entry.
3.5 Snapin specifically couples TRPC6 to the a 1A -AR G q/11 -coupled angiotensin-II type 1 receptors (AT 1 ) are expressed in the heart and can activate TRPC6 in CMs. 30 As shown in Figure 4C , Figure 4E ). These findings indicate that a 1A -AR/Snapin/ TRPC6-mediated Ca 2+ entry is augmented by PLCb-mediated DAG production via an effect at the level of TRPC6.
3.7 Increases in cardiac contractility in WT and a 1A -AR-H mice and sudden cardiac death of a 1A -H mice is prevented by blockade of a 1A -ARs or TRPC6
We reported previously that a 1A -H mice die prematurely of sudden cardiac death manifested by a progressive reduction in QRS amplitude and then in left ventricular pressure. 20 To investigate whether this response involved Ca 2+ entry via a 1A -AR-stimulated TRPC6 activation, we used isolated perfused hearts from a 1A -H mice. As shown in Figure 5B , activation of a 1A -ARs with A61603 mimicked the sudden cardiac death response observed in intact animals, and A61603 washout restored heart function. Administration of either KMD3213 (data not shown) or anti-TRPC6 antibody, but not anti-TRPC1 antibody (data not shown), before A61603-stimulation, prevented the hypercontractile response in both a 1A -H and WT hearts, and completely protected a 1A -H hearts from sudden cardiac death ( Figure 5A and C ). The cardiac haemodynamics in WT and a 1A -H Langendorff-perfused hearts are given in Supplementary material online, Table S1 . These findings provide evidence that a 1A -AR-mediated activation of TRPC6 is a physiologically relevant pathway underlying a 1A -AR-mediated cardiac contractile responses in WT mice and is pathophysiologically involved in sudden cardiac death of a 1A -H mice.
Discussion
Myocardial a 1 -AR signalling pathways remain poorly defined, partly because of low levels of a 1 -AR expression and, thus, limited signal output in normal heart under physiological conditions. The signalling pathway mediating positive inotropic effects of a 1 -ARs has been studied for .30 years but remains enigmatic. The increase in [Ca 2+ ] i associated with a 1 -AR activation in the normal heart is relatively small compared with the increase in force, suggesting that a receptor-stimulated increase in Ca 2+ sensitivity is importantly involved in receptor-coupled increase in contractility. 32 entry involving redirection and activation of TRPC6 from the cytoplasm to the plasmalemma via interaction with Snapin. This in turn enhances cardiac contractility. TRPC6-mediated Ca 2+ entry is also partially modulated by a 1A AR-stimulated activation of G q/11 , and, thus, PLCb, which results in DAG production that independently activates TRPC6 in the plasma membrane ( Figure 6 ). Our data show that in CMs, TRPC6 and Snapin co-localize along the plasma membrane and at the end of sarcomere Z-lines, even in the absence of a 1A -AR stimulation, suggesting that they interact in a pre-formed complex to facilitate rapid ROCE. Consistent with preferential sarcolemmal localization of TRPC6 observed in CMs from cardiac-specific TRPC6 overexpressing mice, 35 we found transloca- entry via a 1A -AR-stimulated TRPC6 channels may be restricted to juxta-membranous microdomains at sites distinct from those involved in b-AR-stimulated Ca 2+ entry. 36 In addition to physiologically regulating a 1A -AR-stimulated cardiac contractility in WT mice, TRPC6, at least to some extent, also appears to be critically involved in the pathophysiology of the sudden cardiac death observed in a 1A -H mice observed in response to increased sympathetic activity. Prevention of sudden cardiac death by a 1A -AR blockade and independently by TRPC6 blockade indicates that this response is a result of excessive a 1A -AR-mediated Ca 2+ entry via TRPC6. Excessive Ca 2+ is known to inhibit gap junction conductance 37 -an effect entirely consistent with the progressive reduction in QRS amplitude without arrhythmias in a 1A -H mice, but one that contrasts with the ventricular fibrillation and sudden cardiac death observed with store-overload-induced Ca 2+ release.
38
In vivo, the a 1A -H model displays a robust increase in systolic contractility (dP/dt max ) with little change in diastolic relaxation (dP/dt min ) and no hypertrophy. 17 Thus, receptor-coupled signalling pathways for contractility and hypertrophy may be spatially and temporally dissociated in CMs, despite the seeming commonality of enhanced [Ca 2+ ] i being required for both. In agreement with this notion is the finding that under physiological conditions, activation of gene transcription programmes can be dissociated from enhanced [Ca 2+ ] i following activation of the prototypical pro-proliferative receptor, the epidermal growth factor receptor. 39 In summary, we have delineated a novel myocardial a 1A -AR signalling pathway that provides significant insights into receptor-regulated cardiac contractility and Ca 2+ handling in the context of both WT a 1A -AR expression, and receptor overexpression. Given that the transgenic model of enhanced a 1A -AR activity displays robust hypercontractility but no hypertrophy, our data suggest that modest activation of the a 1A -AR-Snapin-TRPC6-pathway may be a promising approach for therapeutically augmenting cardiac performance in clinical settings of impaired cardiac performance, such as myocardial infarction or heart failure.
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